GMT — Genomtec SA Balance Sheet
0.000.00%
- PLN91.89m
- PLN83.96m
- PLN0.00m
Annual balance sheet for Genomtec SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | PRESS | ARS | ARS | ARS |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 7.3 | 1.38 | 4.14 | 4.17 | 6.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.584 | 0.643 | 0.685 | 1.97 | 0.879 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8.08 | 2.26 | 4.99 | 6.64 | 8.49 |
| Net Property, Plant And Equipment | 1.24 | 1.07 | 2.19 | 1.75 | 2.61 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9.37 | 6.69 | 11.8 | 16 | 17 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.11 | 1.21 | 2.32 | 3.14 | 5.48 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.8 | 4.21 | 6.87 | 7.67 | 9.44 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 7.57 | 2.48 | 4.89 | 8.3 | 7.6 |
| Total Liabilities & Shareholders' Equity | 9.37 | 6.69 | 11.8 | 16 | 17 |
| Total Common Shares Outstanding |